Improving Implementation of Evidence-based Approaches and Surveillance to Prevent Bacterial Transmission and Infection

ConditionInfection
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorTrustees of Dartmouth College

About this trial

Surgical site infections (SSIs) are associated with increased patient morbidity, mortality, and healthcare costs. ESKAPE (Enterococcus, S. aureus, Klebsiella, Acinetobacter, Pseudomonas, and Enterobacter spp.) pathogens are particularly pathogenic because they have increased capacity to acquire resistance and virulence traits. The investigators have proven that a multifaceted program involving improved basic perioperative preventive measures can generate substantial reductions in S. aureus transmission and significant reductions in SSIs (88% reduction as compared to usual care). In this study, the investigators aim to examine the relative effectiveness of each component of this program in controlling ESKAPE transmission and reducing SSIs and to identify an optimal implementation strategy for national dissemination. Randomization occurs at the site level, and sites adopt preventative programs. This work will improve perioperative patient safety for the 51 million patients who undergo surgery each year.

Eligibility criteria

Qualifiers

None

Disqualifiers

250 patients (125 case pairs) per site in the active phase (N=3,000)

250 patients (125 case pairs) per site in the sustainability phase (N=3,000)

Total N=6,000

orthopedic total joint and spine procedures

Trial design

Treatments tested in this trial

  • Technical assistance or team-based coaching

Treatment groups

6,000 Participants
are divided into 4 treatment groups

Sponsors and collaborators

Trustees of Dartmouth College

Lead sponsor

Mayo Clinic

Collaborator

Georgetown University

Collaborator